ENTITY

CSL (CSL AT)

2
Analysis
Health Care • United States
CSL Limited develops, manufactures, and markets human pharmaceutical and diagnostic products derived from human plasma. The Company provides products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
•20 Aug 2018 20:22

Aussie Reporting Season Update: Cracks in the Mirror

Solid Earnings Momentum Hits a Brick Wall. It’s still early days, with only 40% of stocks reporting during the first 2 weeks of reporting season,...

Logo
580 Views
Share
bullish•Telstra Corp
•18 May 2026 06:10

Aussie Shorts [11 May 2026]: Telstra, Woolworths, Lotus Res., Arafura Res., Mcmillan Shakespeare

The largest industry net increase in the past week was A$1.6bn into "Diversified Meals"; the largest industry net decrease was A$129mn out of...

Logo
121 Views
Share
•14 May 2026 17:59

ASX Short Interest Weekly (May 8th): BHP, Telstra, National Australia Bank, Wesfarmers

We analyzed ASX short interest report for the past week and highlight short interest changes in BHP, Telstra, National Australia Bank, Wesfarmers,...

Logo
109 Views
Share
•21 Mar 2018 18:07

Aussie Equities Model Portfolio Update

Australia is in a sweet spot. We are sticking to the themes and sector positioning outlined in our 2018 outlook.  We still think the ASX200 will...

Logo
306 Views
Share
•13 Dec 2017 17:44

Aussie Healthcare Daily: 12 & 13 Dec 2017

The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare companies as well as developments and trends in...

Logo
542 Views
Share
x